Search for Clinical Trial Results
Coma - 982 Studies Found
Status | Study |
Recruiting |
Study Name: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma Condition: Sarcoma, Alveolar Soft Part Date: 2011-07-09 Interventions:
|
Recruiting |
Study Name: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma Condition: Sarcoma, Alveolar Soft Part Date: 2009-07-18 Interventions: Drug: AZD2171 Cediranib (AZD2171), a VEGF/KIT tyrosine kinase inhibitor, has demonstrated antitumor acti |
Completed |
Study Name: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Condition:
|
Completed |
Study Name: Phase 2 Study in Patients With MiT Tumors Condition:
|
Active, not recruiting |
Study Name: Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma Condition:
|
Not yet recruiting |
Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Condition:
Date: 2016-08-15 Interventions: |
Not yet recruiting |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition:
Interventions: |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition:
|
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition:
|
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition:
Interventions: |